Enveric Biosciences, Inc. Common Stock earnings per share and revenue
On Nov 14, 2025, ENVB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.35 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.30% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.31 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Enveric Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Enveric Biosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Enveric Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.3%, changed from $5.46 before the earnings release to $5.28 the day after.
When is Enveric Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 26, 2026.
What are the forecasts for Enveric Biosciences, Inc. Common Stock's next earnings report?
Based on 3
analysts, Enveric Biosciences, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of -- for Q4 2025.